Objective: To investigate the efficacy of multiday repetitive transcranial magnetic stimulation (rTMS) to the occipital cortex in a patient with continuous visual phosphene hallucinations for more than 2 years following occipital stroke.
Visual hallucinations can be an adverse effect of damage to the occipital cortex (e.g., injury from stroke) in otherwise cognitively healthy individuals. 1, 2 Visual hallucinations can be either simple (phosphenes or unformed) or complex (formed images); however, simple phosphenes are more commonly associated with mesial occipital lobe damage.
The experience of chronic visual hallucinations following visual pathway damage is both mentally and physically exhausting for patients, leading to added psychological consequences that interfere with quality of life. 2, 3 They are frequently poorly managed due to poor understanding of pathogenesis. At present, there are no standard pharmacologic treatment protocols to alleviate visual hallucinations subsequent to visual pathway damage.
A single application of low-frequency repetitive transcranial magnetic stimulation (rTMS) has been reported to temporarily cease intermittent visual hallucinations in a patient following bilateral ischemic damage to occipital cortex. 4 The aim of the present study was to investigate the efficacy of multiday low-frequency rTMS in modulating continuous phosphene hallucinations in a patient following right occipital stroke. We performed functional MRI (fMRI) pre-and post-rTMS and predicted changes in blood oxygen level-dependent (BOLD) signal post-rTMS. Following stroke, the interhemispheric cortical balance becomes modified between the ipsilesional and contralesional hemispheres, 5, 6 resulting in abnormal neuronal activity, and can be targeted with rTMS. 6 rTMS disinhibits interhemispheric transcallosal interactions, a process essential for stroke rehabilitation. 6 We also perform fMRI on an age-matched control sample to enable statistical comparison to a neurologically intact group.
METHODS Standard protocol approvals, registrations, and participant consents. The study was approved by York University's Office of Research Ethics. All individuals gave informed written consent.
Participants. Patient. We evaluated a 31-year-old woman experiencing continuous phosphene hallucinations within an incomplete congruous left homonymous hemianopia (figure 1A) 2.5 years after the onset of right subacute occipital lobe stroke (figure 1B). The phosphene hallucinations began at stroke onset and were described as moving white/gray vibrating images of shattered glass and small-medium circular lights within the scotoma. Occasional high-frequency lightning bolts and irregular zigzags were perceived migrating inferolateral within the scotoma into the normal visual field. Phosphenes were more intense at the relative (incomplete damage) defect, accompanied by macropsia and general distortion. The patient found the constant need to differentiate real percepts and phosphene hallucinations confusing and exhausting despite full awareness the hallucinations were not real. The phosphene hallucinations were perceived at all times; however, intensity increased with stress, lack of sleep, or increasing light intensity, and intensity decreased in the dark or with eyes closed. The phosphene hallucinations were debilitating, interfering with sleep, vision, and quality of life. The e-Methods at Neurology.org contain a detailed patient case history.
The patient had normal foveal vision (.0.2 logMAR) and all other ophthalmic findings were unremarkable. There were no known contraindications to MRI and TMS.
Healthy controls. Eight healthy women (mean age 29 years) with no history of neurologic disorders and no known contraindications to MRI were recruited. All controls had normal or corrected-to-normal vision (.0.2 logMAR) and otherwise normal ophthalmic findings.
Experimental design overview. The patient underwent the following: (1) perimetry and other clinical vision tests, (2) pre-rTMS MRI, (3) sham and vertex rTMS, (4) 5 consecutive days of rTMS, and (5) post-rTMS MRI. Healthy controls underwent (1) and (2) only.
MRI. Stimuli and procedure. We performed 2 fMRI experiments.
The patient self-reported increases in phosphene hallucinations with increasing brightness of visual input and a corresponding decrease in phosphene hallucinations under reduced or dark visual environments. A phosphene localizer was used to delineate cortical origins of the hallucinations. It consisted of 5 full-screen 30-second blocks of white stimulus interleaved with 5 full-screen 30-second blocks of black stimulus, with a continuous central fixation (figure e-1A). A gray screen with central fixation appeared for 30 seconds at the start and finish of the run. Each run lasted 6 minutes and was repeated twice. During the phosphene localizer, the patient indicated change in intensity of perceived phosphene hallucinations using an MRI-compatible response button box. The phosphene localizer was performed first in the patient to prevent any confounds in phosphene hallucinations resulting from viewing previous experimental visual stimuli. A face-place-object (FPO) localizer was performed because the lesion was located in primary visual cortex, which could result in changes in remote visual processing networks connected to both the lesion site and peri-infarct regions. Much of this network contributes to the processing of specialized visual stimuli, mainly faces, places, and objects, which are also implicated in complex visual hallucinations. 7 The purpose of the FPO localizer was to delineate these regions and measure remote activity associated with the lesion and/or changes with rTMS. The FPO localizer consisted of 3 different blocks, each with 16 images: (1) faces (male and female), (2) places (natural and non-natural scenes), (3) objects (natural and manmade) (figure e-1B). Epochs containing 3 blocks of the 3 categories of stimuli were repeated 6 times in a counterbalanced order to minimize first-order carryover effects. Each image was presented for 900 milliseconds with 100 milliseconds interstimulus interval, and images were presented without repetition. A central fixation cross appeared for 16 seconds at the start and finish of the run and between epochs. Each run lasted 6 minutes 52 seconds and was repeated twice.
Localizers were performed immediately prior to and after rTMS treatment ceased. Control participants underwent both localizers to enable comparison. All imaging was acquired in a dark room.
Image acquisition. Functional and anatomical images were acquired with a 3T Siemens Magnetom Tim Trio magnetic resonance scanner (Siemens, Erlangen, Germany), using BOLD fMRI imaging. Functional volumes were acquired using a Siemens 32-channel high-resolution brain array coil and echoplanar imaging with a T1-weighted sequence (32 contiguous axial slices, in-plane resolution 2.5 3 2.5 mm, slice thickness 3.0 mm, imaging matrix 96 3 96, repetition time [TR] 2,000 milliseconds, echo time [TE] 30 milliseconds, flip angle 90 8 , field of view [FoV] 240 mm). Structural images were acquired after functional scans with a T1 magnetization-prepared rapid gradient echo imaging sequence (number of slices 192, in-plane resolution 1 3 1 mm, slice thickness 1.0 mm, imaging matrix 256 3 256, TR 1,900 milliseconds, TE 2.5 milliseconds, inversion time 900 milliseconds, flip angle 9 8 , FoV 256 mm). rTMS procedure. Low-frequency rTMS. Only the patient underwent rTMS treatment. The demarcation between the absolute and relative visual field defect is a functional representation of intact or partially intact neurons with residual recovery of function ( figure 1A ). This suggested disorganized activity from surviving or partially damaged neurons within or around the lesion was confirmed from the restricted disorganization of activity at the lesion border evident from fMRI analysis compared to controls (figure 2). Therefore, we chose the lesion as the target site for rTMS in order to reach the partially damaged neurons.
The lesion was mapped on the patient's anatomical scan and 3D reconstructed cortical surface using Brainsight software (Rogue Research, Montréal, Canada). The spatial relationship between the reference points from the MRI and those on the patient's head were coregistered using a Polaris infrared tracking system (Northern Digital Instruments, Kitchener, Canada) to enable targeted rTMS to the disorganized activity at the border of the lesion. The image-guided stereotaxic system enables accurate coil position over target sites and tracking of the coil with respect to the patient's head during stimulation that can be continuously monitored and corrected in real time. A Magstim Rapid 2 Stimulator and a 70-mm diameter figure-of-eight coil (Magstim, Whitland, Wales, UK), which provides focal stimulation, were used to deliver the stimulation pulses to the targeted stimulation site. A low-frequency pulse (1 Hz) was delivered at 85% of maximum stimulator output (110% visible twitch motor threshold 8 ) for 30 minutes (1,800 pulses). Due to the continuous and variable perception of phosphene hallucinations, motor instead of phosphene threshold measurements were chosen. Lowfrequency rTMS is typically suppressive and was chosen to reduce disorganized activity. Prior to stimulation of the target site, 2 separate control conditions were performed, rTMS to vertex and sham rTMS (coil held orthogonal to the skull and no pulses enter the brain), during which the patient reported no effect. rTMS treatment was then performed daily over 5 days to the target site at the posterior tip of the lesion (Talairach coordinates, x 5 14, y 5 275, z 5 9; ;14 mm deep), which was within penetration limits (10-20 mm). 9 A daily subjective log of rTMS effects on phosphene hallucinations was recorded during and after vertex, sham, and each rTMS session. We recorded the length of time the effects persisted and any changes in perception throughout the day. Subjective changes were reported as a percentage decrease in the self-reported average baseline intensity of phosphene hallucinations that were perceived prior to beginning rTMS treatment. The patient reported the daily average baseline intensity to be 70% (relative to worst intensity previously experienced).
Data analyses. Analyses of fMRI were performed using Brain-Voyager QX (2.8) (Brain Innovation, Maastricht, the Netherlands). Preprocessing steps are described in the e-Methods.
Phosphene localizer. A whole-brain fixed-effects analysis was performed using a linear balanced contrast (white . black), false discovery rate (FDR)-corrected single-voxel threshold of q , Table 1 Phosphene localizer results for the patient 0.05, to compare (1) patient (pre-and post-rTMS separately) and control activation for white and black event predictors. Subtraction analysis [b-difference maps] was performed for the following comparisons: (2) patient's pre-vs post-rTMS phosphene localizer activity; and (3) patient (pre-and post-rTMS separately) vs control phosphene localizer activity. Subtraction of maps was performed for white and black event predictors separately, for voxels above selected b thresholds of .0.5, where b values quantify the level of cortical activity. The e-Methods provide information on the patient's subjective button responses that were not included for further analyses.
FPO localizer. Regions known to be involved in processing of faces, places, and objects (a priori regions) were defined in all individuals independently. The a priori face preferential regions included the fusiform face area (FFA) and occipital face area (OFA). The scene preferential regions included the transverse occipital sulcus (TOS), parahippocampal place area (PPA), and lingual gyrus (LG). The object preferential region involved the lateral occipital area (LO). A priori regions were defined using a linear balanced contrast and were identified individually for each participant by determining the peak selective activation for the region in question, FDR-corrected single-voxel threshold of q , 0.05. Activity within a priori regions was quantified from the event-related time course as b weights. We used the modified t test (2-tailed tests) developed for single-case studies to compare patient to controls. 10, 11 The e-Methods provide a detailed description of identifying the a priori regions.
RESULTS Subjective perception of phosphene
hallucinations. The patient reported a gradual reduction in phosphene hallucinations with increased application of rTMS. Effects summated with increased time of rTMS application during each session. With each new day of rTMS treatment, hallucinations were modulated faster and effects continued to summate and last longer. As a result, with each new day, the patient also reported an overall improvement in well-being, described as being less mentally and physically exhausted (figure e-2). Effects of rTMS were maintained after discontinuation of stimulation with a gradual linear return to baseline intensity. The perception of phosphene hallucinations did not completely cease during the treatment; however, they were reduced to less than 15% intensity (figure e-2). In addition, the patient reported minimal distortion and macropsia after rTMS treatment; however, this reduction was not quantified.
MRI. Phosphene localizer. The anatomical regions with significant differences in activation between white and black stimuli (white . black) for the patient (pre-and post-rTMS) and controls are detailed in tables 1 and 2, respectively. Figure 2 highlights the most notable difference in patterns of cortical activity, not only between the patient and controls, but a remarkable difference is seen between the patient pre-and post-rTMS. Pre-rTMS, a greater concentration of diffuse activity is observed in the contralesional hemisphere at the lingual gyrus and cuneus, while ipsilesional activity was focal to the calcarine sulcus and anterior to the lesion in the patient. Unlike the patient, controls did now show activation at the lingual gyrus in dark (black stimuli) viewing conditions. Subtraction analysis of the phosphene localizer providing b difference maps for the patient preand post-rTMS, the patient pre-rTMS and controls, and for the patient post-rTMS and controls are shown in tables e-1, e-2, and e-3, respectively.
FPO localizer. The a priori analysis and the modified t test results are shown in figure 3. Differences are observed in processing requirements allocated within the regions for preferential and nonpreferential taskspecific processing between the patient and controls. Compared to controls, pre-rTMS the patient displayed greater selectivity to places in the scene preferential region left TOS, but reduced place selectivity (greater nonpreferential processing) in the right TOS and right lingual gyrus. Within the left LO, typically an object preferential region, pre-rTMS the patient showed greater nonpreferential processing of faces and reduced nonpreferential processing of places compared to controls. Greater face selectivity was observed in the bilateral face preferential region OFA. Post-rTMS, in some cases, there was redistribution of activity in preferential and nonpreferential processing towards a similar level of activation to that of controls.
DISCUSSION Using rTMS, we greatly reduced the perception of phosphenes in our patient with chronic continuous phosphene hallucinations following occipital stroke. These effects summated daily and outlasted stimulation. rTMS did not simply reduce activity in the previously disorganized regions of activity contributing to the perception of phosphene hallucinations, but redistributed imbalanced activity throughout the brain to a level similar to that of controls, presumably through disinhibition of intrahemispheric and interhemispheric interactions. Several differences in cortical activity were observed between the patient pre-rTMS and controls (tables 1, 2, and e-2) that implicate these regions in the origins of the patient's phosphene hallucinations. Electrical stimulation to V1, the calcarine sulcus, and the visual association area Brodmann area 18 induces the perception of phosphenes, 12, 13 supporting our results and the involvement of these regions (figure 2) in the genesis of phosphene hallucinations in this patient.
Activation in the anterior vermis of the cerebellum in the patient pre-rTMS when viewing bright and dark stimuli (tables 1 and 2) is consistent with its role in mental imagery. 14 The cerebellum also shows connectivity to the dorsal visual stream and visual cortices, as well as involvement in visual attention to moving stimuli. 15 Another explanation for visual hallucinations is that areas involved in memory retrieval including categoryspecific visual areas may release percepts from memory when sensory impulses that are excluded from consciousness are no longer inhibited following damage. 13 The middle temporal gyrus is implicated in object recognition memory 16 and is consistent with differences of activation observed in the middle temporal gyrus between the patient pre-rTMS and controls (tables 1 and 2).
The claustrum regulates communication across the brain via cholinergic mechanisms. Cholinergic input inhibits GABAergic inhibitory input from the reticular nucleus. 17 Release of visual association cortex with loss of cortico-cortical inputs after stroke 18 alters cortical activity via reticular activating system by decreasing cholinergic input that is linked to hallucinations. 19 The involvement of the claustrum in the patient pre-rTMS (table e-2) is consistent with evidence of its involvement in visual hallucinations.
These regions may be directly involved in the origin of hallucinations (the cause) or may be indirectly activated as a function-specific response to the continuous perception of the recurrent phosphene hallucinations (the effect). Ultimately, aberrant processes result in pathologic feedback between cortical regions. 1, 19 Following 5 days of consecutive application of rTMS to the visual cortex in the patient, a balance of activation was observed across the brain post-rTMS, both interhemispherically and intrahemispherically (figure 2). This included deactivation of regions in the patient pre-rTMS that were not observed in controls, or conversely activation of regions that were observed in controls but not in the patient pre-rTMS (tables 1, 2, e-2, and e-3). Thus, post-rTMS activation in the patient was similar to neural processes in controls within these regions.
A priori analysis of the FPO localizer following rTMS revealed neural resources were transferred between preferential and nonpreferential selectivity of regions. Although controls did not undergo rTMS in this study, our previous research shows no changes in stimulus category selectivity in these regions following rTMS to the visual cortex in healthy controls. 20, 21 The redistribution of activation across the brain with rTMS demonstrates rTMS was not restricted in its effects to the targeted region in the occipital lobe but rather led to a more global redistribution of activity in remotely connected regions.
Nonetheless, the patient continued to demonstrate some differences post-rTMS compared with controls (table e-3). The residual activity, particularly at the border of the lesion, demonstrates persistent neuronal firing, which corresponds to the continued yet greatly reduced perception of phosphene hallucinations after rTMS treatment.
The pattern of cortical activity following rTMS is not perfectly equivalent to that of controls. Similarly, we do not see the typical inhibition of activity at the stimulation site following rTMS that we observe in healthy controls. 21, 22 In the deafferented cortex, there is an increase of membrane resistance that may cause an excitability of the involved regions, 23 therefore reducing the susceptibility to inhibition. It is likely that remote stimulation effects and restoration to normal function were limited due to impaired inhibitory mechanisms in the patient.
In order to overcome limitations of a single-case study, our future work will test a larger sample and include more objective fMRI testing. To maximize functional recovery and prevent the development of abnormal perceptual processing, it is likely that rTMS treatment needs to be applied as soon as possible poststroke within the plasticity window for recovery. 24, 25 Due to our limited time with this patient, we were unable to further refine stimulation intensity and duration in order to achieve maximal phosphene suppression. Our future work will refine these stimulation parameters.
A number of conditions present with secondary visual hallucinations (e.g., Parkinson disease, schizophrenia, Charles Bonnet syndrome) that share analogous mechanisms of dysfunction of mutually implicated neurotransmitters, interhemispheric imbalance, and involvement of common brain regions. Neuromodulation with rTMS could provide a valuable tool for effective treatment of visual hallucinations in these populations.
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